Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 228

recruiting
3 973
countries
28
conditions
2 104

10 286 trials match your criteria

Study on Imaging Multiple Myeloma Patients Using Fluciclovine (18F) PET/CT

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Fluciclovine (18F)

Study on Apathy in Stroke Patients Using Fluoroethoxybenzovesamicol F-18 and Fluorodopa (18F)

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorodopa (18F)

Study of Capecitabine and Pembrolizumab for Patients with Triple Negative Breast Cancer After Chemoimmunotherapy and Surgery

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine

Study on Valproic Acid, Simvastatin, and Gemcitabine for Untreated Metastatic Pancreatic Cancer Patients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine

Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cyclophosphamide

Rectal cancer

Recruiting

Study of Durvalumab with Drug Combination for Patients with Locally Advanced Rectal Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate

Iron deficiency

Recruiting

Study on the Effects of Intravenous Ferric Derisomaltose in Non-Anemic Iron Deficient Patients with Colorectal Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose

Study on Istradefylline for Reducing Brain Inflammation in Patients with Progressive Multiple Sclerosis

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Istradefylline

Study on Zoledronic Acid Use After Stopping Denosumab in Women with Postmenopausal Osteoporosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Zoledronic Acid

Cartilage injury+2

Recruiting

Study on the Effectiveness of Lenzumestrocel for Treating Knee Cartilage Defects in Patients

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Lenzumestrocel

Osteomyelitis+1

Recruiting

Study on Treating Acute Osteomyelitis in Children with Amoxicillin and Cloxacillin Compared to Standard Hospital Care

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Amoxicillin
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.